Entity
  • Cellarity

    Created in 2017
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    13,992
  • Activities

  • Technologies

  • Entity types

  • Location

    101 South St 6th Floor, Somerville, MA 02143, USA

    Somerville

    United States of America

  • Employees

    Scale: 51-200

    Estimated: 136

  • Engaged corporates

    3
    0 3
  • Added in Motherbase

    9 months ago
Description
  • Value proposition

    Rewriting the rules of drug creation

    Cellarity is fundamentally redesigning the way drugs are created. By shifting the focus from a single target to the underlying cellular dysfunction, the company unravels the complexity of disease biology to create medicines that are out of reach with the target-based drug discovery approach. Founded by Flagship Pioneering in 2017, Cellarity has developed a platform that utilizes proprietary AI models trained on over 30 million single cell transcriptomes to uncover novel actionable biology and create non-intuitive drug candidates in a vast array of diseases. The company currently has programs ongoing in several disease areas including those in metabolic disease, hematology, and immuno-oncology.

    Drug Discovery, Drug Development, Single Cell Technologies, AI, Artificial Intelligence, and Machine Learning

Corporate interactions BETA
Corporate TypeTweets Articles
Dia & Co
Dia & Co
Semiconductors, Retail Apparel and Fashion
Dia & Co
Semiconductors, Retail Apparel and Fashion
Other

6 Oct 2024


Novartis
Novartis
Pharmaceutical, Pharmaceutical Manufacturing
Novartis
Pharmaceutical, Pharmaceutical Manufacturing
Other

6 Oct 2024


Novo Nordisk
Novo Nordisk
Pharmaceutical, Pharmaceutical Manufacturing
Novo Nordisk
Pharmaceutical, Pharmaceutical Manufacturing
Other

6 Oct 2024


Similar entities
Loading...
Loading...
Social network dynamics